1. Home
  2. SIG vs MLTX Comparison

SIG vs MLTX Comparison

Compare SIG & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIG
  • MLTX
  • Stock Information
  • Founded
  • SIG 1950
  • MLTX 2021
  • Country
  • SIG Bermuda
  • MLTX Switzerland
  • Employees
  • SIG N/A
  • MLTX N/A
  • Industry
  • SIG Consumer Specialties
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SIG Consumer Discretionary
  • MLTX Health Care
  • Exchange
  • SIG Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • SIG 3.1B
  • MLTX 2.8B
  • IPO Year
  • SIG N/A
  • MLTX N/A
  • Fundamental
  • Price
  • SIG $90.50
  • MLTX $59.72
  • Analyst Decision
  • SIG Buy
  • MLTX Strong Buy
  • Analyst Count
  • SIG 6
  • MLTX 7
  • Target Price
  • SIG $100.67
  • MLTX $74.83
  • AVG Volume (30 Days)
  • SIG 1.1M
  • MLTX 421.3K
  • Earning Date
  • SIG 09-02-2025
  • MLTX 08-05-2025
  • Dividend Yield
  • SIG 1.42%
  • MLTX N/A
  • EPS Growth
  • SIG N/A
  • MLTX N/A
  • EPS
  • SIG 3.04
  • MLTX N/A
  • Revenue
  • SIG $6,778,700,000.00
  • MLTX N/A
  • Revenue This Year
  • SIG $1.41
  • MLTX N/A
  • Revenue Next Year
  • SIG $1.07
  • MLTX N/A
  • P/E Ratio
  • SIG $29.65
  • MLTX N/A
  • Revenue Growth
  • SIG N/A
  • MLTX N/A
  • 52 Week Low
  • SIG $45.55
  • MLTX $31.42
  • 52 Week High
  • SIG $106.28
  • MLTX $61.87
  • Technical
  • Relative Strength Index (RSI)
  • SIG 60.38
  • MLTX 69.87
  • Support Level
  • SIG $85.31
  • MLTX $53.18
  • Resistance Level
  • SIG $91.85
  • MLTX $61.87
  • Average True Range (ATR)
  • SIG 3.72
  • MLTX 2.44
  • MACD
  • SIG 0.62
  • MLTX 0.41
  • Stochastic Oscillator
  • SIG 78.78
  • MLTX 78.17

About SIG Signet Jewelers Limited

Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Share on Social Networks: